Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Endocr Disord ; 21(1): 165, 2021 Aug 14.
Article in English | MEDLINE | ID: mdl-34391409

ABSTRACT

BACKGROUND: Betel-nut consumption is the fourth most common addictive habit globally and there is good evidence linking the habit to obesity, type 2 diabetes (T2D) and the metabolic syndrome. The aim of our pilot study was to identify gene expression relevant to obesity, T2D and the metabolic syndrome using a genome-wide transcriptomic approach in a human monocyte cell line incubated with arecoline and its nitrosated products. RESULTS: The THP1 monocyte cell line was incubated separately with arecoline and 3-methylnitrosaminopropionaldehyde (MNPA) in triplicate for 24 h and pooled cDNA indexed paired-end libraries were sequenced (Illumina NextSeq 500). After incubation with arecoline and MNPA, 15 and 39 genes respectively had significant changes in their expression (q < 0.05, log fold change 1.5). Eighteen of those genes have reported associations with T2D and obesity in humans; of these genes there was most marked evidence for CLEC10A, MAPK8IP1, NEGR1, NQ01 and INHBE genes. CONCLUSIONS: Our preliminary studies have identified a large number of genes relevant to obesity, T2D and metabolic syndrome whose expression was changed significantly in human TPH1 cells following incubation with betel-nut derived arecoline or with MNPA. These findings require validation by further cell-based work and investigation amongst betel-chewing communities.


Subject(s)
Areca/chemistry , Arecoline/pharmacology , Diabetes Mellitus, Type 2/genetics , Gene Expression Regulation/drug effects , Metabolic Syndrome/genetics , Monocytes/metabolism , Obesity/genetics , Transcriptome/drug effects , Biomarkers/analysis , Biomarkers/metabolism , Follow-Up Studies , Humans , Monocytes/drug effects , Monocytes/pathology , Pilot Projects , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL